Bao-Xia Dong

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Combination Therapy

Top Venues

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hong-Yuan Shen, Hai-Long Tang, Yan-Hua Zheng, Juan Feng, Bao-Xia Dong, Xie-Qun Chen
The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects. Journal of oncology 2022 (2022)